Katabi Maha has filed 12 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 14000 shares of Vera Therapeutics, Inc. ($VERA) on May 14, 2025.
Activity breakdown: 1 open-market purchase and 6 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2025 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 63,748,290 | 9999.99% | 0.02% |
| June 5, 2024 | Jade Biosciences, Inc. | $JBIO | Katabi Maha | Not found | A | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 0 | 9999.99% | 0.00% |
| May 15, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Not found | A | Stock Option (right to buy) | 14000 | $0.00 | 14,000.0000 | 0 | 9999.99% | 0.00% |
| March 21, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | S | Class A Common Stock | 12617 | $45.52 | 3,561,155.0000 | 0 | 0.35% | 0.00% |
| March 21, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | S | Class A Common Stock | 13718 | $46.18 | 3,547,437.0000 | 0 | 0.39% | 0.00% |
| March 25, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | S | Class A Common Stock | 340000 | $40.50 | 2,793,987.0000 | 0 | 10.85% | 0.00% |
| March 22, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | S | Class A Common Stock | 413450 | $40.51 | 3,133,987.0000 | 0 | 11.65% | 0.00% |
| March 21, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | S | Class A Common Stock | 32756 | $43.00 | 3,595,690.0000 | 0 | 0.90% | 0.00% |
| March 21, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | S | Class A Common Stock | 21918 | $44.00 | 3,573,772.0000 | 0 | 0.61% | 0.00% |
| Jan. 30, 2024 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | P | Class A Common Stock | 161290 | $31.00 | 3,628,446.0000 | 0 | 4.65% | 0.00% |
| Jan. 2, 2024 | Jade Biosciences, Inc. | $JBIO | Katabi Maha | Not found | A | Stock Option (Right to Buy) | 3519 | $13.49 | 3,519.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2023 | Vera Therapeutics, Inc. | $VERA | Katabi Maha | Director | A | Stock Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |